Business Context and Reporting Period
Company: Optex Systems Holdings Inc (OPXS)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and six months ended March 29, 2026
Business Overview: Manufacturer of optical sighting systems and assemblies for U.S. Department of Defense, foreign military, and commercial markets. Operations are split into two segments: Optex Richardson (military land vehicle systems) and Applied Optics Center (optical assemblies and laser filters).
Key Event: Leadership transition occurred in December 2025 with Chad George assuming the role of CEO.
Key Financial Metrics
| Metric (in thousands) | 3 Months Ended Mar 29, 2026 |
3 Months Ended Mar 30, 2025 |
6 Months Ended Mar 29, 2026 |
6 Months Ended Mar 30, 2025 |
|---|---|---|---|---|
| Revenue | $9,627 | $10,730 | $18,772 | $18,928 |
| Gross Profit | $3,392 | $3,361 | $5,488 | $5,489 |
| Gross Margin | 35.2% | 31.3% | 29.2% | 29.0% |
| Operating Income | $1,664 | $2,237 | $1,813 | $3,153 |
| Net Income | $1,341 | $1,768 | $1,583 | $2,612 |
| Diluted EPS | $0.19 | $0.26 | $0.23 | $0.38 |
| Cash & Equivalents | $4,164 (as of Mar 29, 2026) | |||
| Working Capital | $22,558 (as of Mar 29, 2026) | |||
| Debt (Revolving Credit) | $0 Outstanding |
Material Changes vs. Prior Period
- Revenue Decline: Quarterly revenue decreased 10.3% ($1.1M) and six-month revenue decreased 0.8% ($0.2M). The decline was primarily driven by the Applied Optics Center segment due to the U.S. federal government shutdown (Oct-Nov 2025) and delayed appropriations, which deferred contract awards.
- Margin Expansion: Despite lower revenue, gross margins improved to 35.2% (Q/Q) and 29.2% (YTD). This was driven by the completion of legacy loss-making contracts at Optex Richardson and favorable adjustments to warranty and contract loss reserves at Applied Optics Center.
- Operating Expense Increase: General and Administrative (G&A) expenses increased significantly ($0.6M Q/Q, $1.3M YTD). This was attributed to executive leadership transition costs (overlapping CEO compensation), new General Manager hiring, and increased stock-based compensation ($0.2M Q/Q increase).
- Cash Flow: Operating cash flow turned negative ($1.3M used) for the six months ended March 29, 2026, compared to $4.0M provided in the prior year. This was primarily due to a $1.3M increase in inventory levels and changes in working capital.
Guidance, Outlook, and Risks
- Outlook: Management anticipates a strong revenue rebound in the second half of fiscal year 2026 as deferred orders from the government shutdown are recognized. Growth is expected in laser filters and optical assemblies.
- Backlog: Total backlog decreased 10.9% to $36.6 million. Optex Richardson backlog declined 18.7% due to the completion of long-duration periscope contracts, while Applied Optics Center backlog increased 12.9% driven by commercial orders.
- Stock Repurchase: A new $10 million stock repurchase program was approved on February 9, 2026. No shares have been repurchased to date.
- Risks:
- Government Funding: Revenue is heavily dependent on U.S. government appropriations and defense spending priorities.
- Legacy Contracts: One remaining legacy contract is in a loss condition due to inflationary pressures on materials and labor, though it represents a small portion of backlog.
- Supply Chain: Potential price increases for acrylic raw materials due to geopolitical conflicts in the Middle East.
Investor Verification Checklist
- Deferred Revenue Timing: Verify the expected timing of revenue recognition for orders deferred due to the 2025 government shutdown to assess H2 2026 performance.
- Legacy Contract Status: Monitor the remaining loss-making contract to ensure cost overruns do not exceed current reserves ($56k).
- Expense Run Rate: Confirm if G&A expenses will normalize post-transition or remain elevated due to new organizational structures and CMMC compliance costs.
- Inventory Levels: Assess the $1.3M increase in inventory to ensure it aligns with anticipated demand and does not indicate obsolescence risks.
- Stock-Based Compensation: Review the amortization schedule for the new market-based equity awards granted to the CEO and CFO in December 2025.